-
Watch the Recording: Advocating for A Successful School Year
Recently, PPMD’s Alexis Hazlett was joined by panelists Jodi Krause (Colorado Children’s Hospital), Jill Castle, […]
-
Teaching students about life with limb-girdle muscular dystrophy
As most of America’s children go back to school, I thought it’d be timely to […]
-
How my late brother and I left a mark on our DMD community
While observing World Duchenne Awareness Day over the weekend, I reflected on the journey my […]
-
Lessons that come from a long journey with DMD
I walked home from school today. I’m almost 45 years old, yet today, with my […]
-
DYNE-251 leads to improvements in motor function in DMD: Update
Up to a year of treatment with DYNE-251, Dyne Therapeutics’ investigational exon 51-skipping therapy, led […]
-
Raising Our Voices for Duchenne: Recap of PPMD’s Advocacy Webinar
On Thursday, September 5, 2024, PPMD hosted a special webinar, “PPMD Advocacy: Raising Our Voices […]
-
Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program
SEE THE FULL PRESS RELEASE BELOW AND HERE – Second annual DREAMS Grant Program awards […]
-
Myology Course Educates and Advances Next Generation of Neuromuscular Physicians and Scientists
PPMD is dedicated to fighting for every future as we strive to end Duchenne. Since […]
-
CureDuchenne Submits Comments on FDA’s Draft Guidance for Industry on Platform Technology Designation Program
CureDuchenne welcomes the recent initiative the Food and Drug Administration (FDA) has taken to improve […]
-
Noninvasive qMRI seen to detect muscle changes in LGMD type R1
A noninvasive quantitative MRI, or qMRI, was found to detect early muscle abnormalities among people […]
